NEW YORK, Aug. 8, 2019 /PRNewswire/ -- WeissLaw LLP is
conducting an active investigation of possible breaches of
fiduciary duty and other violations of law by the Board of
Directors of Cambrex Corp. ("Cambrex" or the "Company") (NYSE:
CBM) in connection with the proposed acquisition of the Company by
private equity firm Permira Funds ("Permira"). Under the
terms of the acquisition agreement, Cambrex shareholders will
receive $60.00 per CBM share.
If you own CBM shares and wish to discuss this
investigation or have any questions concerning this notice or your
rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Visit our website
http://www.weisslawllp.com/cambrex-corp/
Or follow us on Twitter @MarketsAlert
WeissLaw is investigating whether Cambrex's
Board acted to maximize shareholder value prior to entering
into the acquisition agreement. Notably, the per-share offer
is $9.43 lower than the Company's
52-week high of $69.43.
Additionally, the deal is a lopsided transaction from which Permira
will greatly benefit. Cambrex is an industry leader, with a
strong foothold in contract development and manufacturing in the
small molecular space. In the last several years, the Company
has broadened its relationship with its customers over the full
lifecycle of its products, from the pre-clinical stages to the
commercial phase.
Given these facts, WeissLaw is concentrating its investigation
on whether the acquisition enhances shareholder value.
WeissLaw is also concerned whether the proposed acquisition
undervalues the Company, and whether all material information
related to the proposed acquisition is fully and fairly
disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-cambrex-corp-300899092.html
SOURCE WeissLaw LLP
